Study Evaluating Intravitreal hI-con1™ in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Inclusion Criteria: * Males or females of any race at least 50 years of age * Active primary Choroidal Neovascularization (CNV) secondary to Age-Related Macular Degeneration (AMD) in the study eye * Best Corrected Visual Acuity (BCVA) of 70 to 24 letters (worse than 20/40 up to 20/320) in the study eye Exclusion Criteria: * Monocular patient or patient with a BCVA of 35 or fewer letters (20/200 or worse) in the better seeing eye * Any prior treatment of CNV or advanced AMD in the study eye, except for dietary supplements or vitamins * Any intraocular or ocular surface surgery (including cataract surgery and laser procedures) in the study eye within 3 months * Vitrectomy in the study eye * Hereditary or chronic hemorrhagic or coagulopathy conditions (i.e., hemophilia)